bioAffinity Technologies, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
6.00
|
|
Average Rating
|
4.00
|
|
# Strong Buys
|
0
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2024-09-30
|
0.00
|
-0.16
|
0.00
|
0.00%
|
|
2024-06-30
|
-0.17
|
-0.19
|
-0.02
|
-11.76%
|
|
2024-03-31
|
-0.20
|
-0.26
|
-0.06
|
-28.35%
|
|
2023-12-31
|
-0.20
|
0.00
|
0.20
|
100.00%
|
|
2023-09-30
|
-0.15
|
-0.26
|
-0.11
|
-73.33%
|
|
2023-06-30
|
-0.13
|
-0.20
|
-0.07
|
-53.85%
|
|
2023-03-31
|
-0.21
|
-0.18
|
0.03
|
14.29%
|
|
2022-12-31
|
-0.19
|
-0.19
|
0.00
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2024-09-30
|
-0.61
|
|
2023-12-31
|
-0.64
|
|
2022-12-31
|
-1.29
|